Michael Bishop

Dr. Bishop is the Director of the Hematopoietic Cellular Therapy Program, Director of the David and Etta Jonas Center for Cellular Therapy, and Professor of Medicine at the University of Chicago. Dr. Bishop joined the National Cancer Institute in March 1999 to serve as the Clinical Head of the Stem Cell Transplantation Program. In 2003, he received the National Institutes of Health Distinguished Clinical Teacher Award. He received tenure as Senior Investigator at NIH in 2007. In 2009 he organized and co-chaired the First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation. In 2011 Dr. Bishop’s was appointed as Head of the Hematologic Malignancies Section in the Division of Hematology and Oncology at the Medical College of Wisconsin/Froedtert Hospital in Milwaukee. In 2012, Dr. Bishop was recruited to serve as the director of the University of Chicago Hematopoietic Stem Cell Transplantation Program and was appointed Professor of Medicine in the Division of Hematology and Oncology, Department of Medicine at the University of Chicago. In 2013, Dr. Bishop was named a Bucksbaum Institute for Clinical Excellence Master Clinician. In 2020, Dr. Bishop was named the Director of the David and Etta Jonas Center for Cellular Therapy at the University of Chicago.